These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 7345967

  • 1. Effect of a new bifunctional nitrosoureido derivative on human colorectal tumor xenografts.
    Kopper L, Lapis K, Csányi E, Horváth T.
    Anticancer Res; 1981; 1(4):229-33. PubMed ID: 7345967
    [Abstract] [Full Text] [Related]

  • 2. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD, Millar JL, McElwain TJ.
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [Abstract] [Full Text] [Related]

  • 3. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
    Vassal G, Boland I, Terrier-Lacombe MJ, Watson AJ, Margison GP, Vénuat AM, Morizet J, Parker F, Lacroix C, Lellouch-Tubiana A, Pierre-Kahn A, Poullain MG, Gouyette A.
    Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a new nitrosoureido water-soluble sugar, ecomustine or CY 233 (NSC 609224), on human xenografts.
    Dumont P, Atassi G, Roger P.
    In Vivo; 1990 Feb; 4(1):61-4. PubMed ID: 2103843
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapeutic sensitivity of human colorectal tumor xenografts.
    Kopper L, Lapis K, Hegedüs C.
    Oncology; 1980 Feb; 37 Suppl 1():42-50. PubMed ID: 7454200
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S, McGuire JJ, Rustum YM.
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [Abstract] [Full Text] [Related]

  • 15. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
    Marcantonio D, Panasci LC, Hollingshead MG, Alley MC, Camalier RF, Sausville EA, Dykes DJ, Carter CA, Malspeis L.
    Cancer Res; 1997 Sep 15; 57(18):3895-8. PubMed ID: 9307267
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
    Houghton JA, Maroda SJ, Phillips JO, Houghton PJ.
    Cancer Res; 1981 Jan 15; 41(1):144-9. PubMed ID: 7448754
    [Abstract] [Full Text] [Related]

  • 19. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
    Schold SC, Kokkinakis DM, Rudy JL, Moschel RC, Pegg AE.
    Cancer Res; 1996 May 01; 56(9):2076-81. PubMed ID: 8616853
    [Abstract] [Full Text] [Related]

  • 20. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N, Nagasu T, Fujita F, Watanabe T, Tsukahara K, Funahashi Y, Fujita M, Taguchi T, Yoshino H, Kitoh K.
    Cancer Res; 1994 Apr 01; 54(7):1702-6. PubMed ID: 8137285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.